In this paper, we describe the Dutch pharmaceutical market, which is heavily regulated by
the government. Through the regulation of prices and promoting prudent use, the Dutch …

BACKGROUND: To address the impact that out-of-pocket prices may have on medication
use, it is vital to understand how the demand for medications may be affected when patients …

Background Little information exists on how constantly growing pharmaceutical
expenditures are distributed in large representative samples of national populations in …

BACKGROUND: Rising costs of pharmaceuticals are a challenge to the public health care
system. In collaboration with a company health insurance with 3143 members we analysed …

Income motivation among general practitioners (GPs) is frequently discussed in the health
economics literature. The question addressed in the present study on reimbursement drugs …

Objective: Germany spends the highest share (10.4%) of its gross domestic product on
health care among European Union countries. The majority of this financing comes from an …

Objective. To quantify the relative and absolute importance of different factors contributing to
increases in per capita prescription drug costs for a population of Canadian seniors. Data …

In this paper we analyse all General Practitioners (GP) prescriptions in a Friuli-Venezia
Giulia area (North-eastern Italy). The sample included of 181 GPs and 242,564 patients with …

Background Pharmaceuticals, while central to medical therapy, pose a significant burden to
health care budgets. Therefore regulations to control prescribing costs and improve quality …

Purpose–The purpose of this study is to estimate the own-and cross-price elasticity of brand-
name outpatient prescription drug cost-sharing for maintenance medications and to estimate …